Fatty Acid-Binding Proteins 4 and 5 Are Involved in the Pathogenesis of Retinal Vascular Diseases in Different Manners

• Published in: Life (Basel, Switzerland) Vol. 12; no. 4; p. 467
• Main Authors: Higashide, Megumi, Furuhashi, Masato, Watanabe, Megumi, Itoh, Kaku, Suzuki, Soma, Umetsu, Araya, Tsugeno, Yuri, Ida, Yosuke, Hikage, Fumihito, Ohguro, Hiroshi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 23.03.2022; MDPI
• Subjects: Age; Blood circulation; Blood flow; Blood pressure; Diabetes mellitus; Diabetic retinopathy; Enzyme-linked immunosorbent assay; Fasting; Fatty acid-binding protein; fatty acid-binding protein 5 (FABP5); Fatty acids; fatty-binding protein 4 (FABP4); Females; Gender; Glucose; Growth factors; Immunoassays; Lipids; Males; Occlusion; Pathogenesis; Patients; proliferative diabetic retinopathy (PDR); Proteins; Regression analysis; Retina; retinal vascular disease (RVD); retinal vein occlusion (RVO); Retinopathy; Triglycerides; Vascular diseases; Vascular endothelial growth factor; vascular endothelial growth factor A (VEGFA); vascular endothelial growth factor A (VEGFA); retinal vascular disease (RVD); fatty-binding protein 4 (FABP4); fatty acid-binding protein 5 (FABP5); proliferative diabetic retinopathy (PDR); retinal vein occlusion (RVO)
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life12040467

This study reports on the pathological significance of the vitreous fatty acid-binding protein (Vt-FABP) 4 and 5, and vascular endothelial growth factor A (Vt-VEGFA) in patients with retinal vascular diseases (RVDs) including proliferative diabetic retinopathy (PDR) and retinal vein occlusion (RVO). Subjects with PDR (n = 20), RVO (n = 10), and controls (epiretinal membrane, n = 18) who had undergone vitrectomies were enrolled in this study. The levels of Vt-FABP4, Vt-FABP5, and Vt-VEGFA were evaluated by enzyme-linked immunosorbent assays (ELISA). Retinal circulation levels were measured by a laser-speckle flow analyzer (LSFA) and other relevant data were collected. The Vt-FABP5 levels were significantly (p < 0.05) elevated in patients with RVDs compared to control patients. This elevation was more evident in patients with RVO than with PDR. Log Vt-FABP5 was significantly correlated negatively or positively with all the LSFA retinal circulation indexes or Log triglycerides (r = 0.31, p = 0.031), respectively. However, the elevations in the Vt-FABP4 and Vt-VEGFA levels were more evident in the PDR group (p < 0.05) and these factors were correlated positively with Log fasting glucose and negatively with some of the LSFA retinal circulation indexes. Multivariable regression analyses indicated that the LSFA blood flows of the optic disc at baseline was an independent effector with Log Vt-FABP5 other than several possible factors including age, gender, Log triglycerides, Log Vt-FABP4 and Log Vt-VEGFA. These current findings suggest that Vt-FABP5 is involved in the pathogenesis of RVD in a manner that is different from that for Vt-FABP4 and Vt-VEGFA, presumably by regulating retinal circulation.